Oral Dutasteride Before and After: Ultimate Guide

Commissions we earn from partner links on this page do not affect our opinions or evaluations.

Many Follicle Thought readers will have likely tried or are taking different pharmaceutical treatments for hair loss. Some might be disappointed by the regrowth achieved, and others may have responded exceptionally well, seeing dramatic results in a short period of time. In part, the disappointment felt may be due to seeing online anecdotes of “hyper-responders” to dutasteride treatments, which can lead to higher expectations.

In this article, we are going to take a look at the available clinical evidence for oral dutasteride, determine what the “typical” result would likely be (the probable result), and explore ten oral dutasteride before and after photos to see what the possible results could be.

First, we’ll give you a brief overview of what androgenic alopecia (AGA) is and how dutasteride fits into its treatment.

AGA is the most common form of hair loss, affecting both men and women. It is characterized by the following:

• Miniaturization: Hair follicles gradually shrink, producing finer, shorter hairs until only vellus (peach fuzz) remains. This process is progressive and primarily affects the front, top, and vertex scalp¹. 
• DHT influence: Dihydrotestosterone (DHT), a potent androgen, binds to receptors in susceptible hair follicles, shortening the growth (anagen) phase and triggering miniaturization². DHT is produced from testosterone by the enzyme 5-alpha-reductase. 
• Genetics: Genetic predisposition is a major factor in determining who develops AGA³. Key genes, especially variations in the androgen receptor (AR), make some people more sensitive to DHT’s effects. 

Dutasteride inhibits both type I and type II forms of the 5α-reductase enzyme, which is responsible for converting testosterone to DHT. By targeting both isoforms, dutasteride achieves a near-total suppression of DHT, reducing circulating DHT levels by as much as 98%. This level of reduction is notably higher than that achieved by finasteride, which lowers DHT by about 65–70%^4,5.

Order oral dutasteride today from our #1 recommended hair loss telemedicine service — Ulo

Setting Realistic Expectations

Regardless of where you are in your treatment journey, it’s important to set realistic expectations for your regrowth.

Some individuals hope for dramatic regrowth, influenced by online testimonials or dutasteride before-and-after photos of “hyper responders.” When their results end up being modest or average, these individuals may feel disappointment, frustration, or lowered self-esteem. Conversely, people with very low expectations might skip effective treatments, missing improvements that would benefit their quality of life.

Another important issue is the reliability of online before-and-after photos and personal anecdotes. These images and stories can be misleading, since they are not standardized, often highlight unusual success cases, and rarely account for variations such as lighting, hair styling, camera angles, or digital enhancements, all factors that can distort perceptions of efficacy.​

A key factor in the above issue is the concept of survivorship bias. 

Survivorship bias occurs when the experiences that are most visible or frequently shared are not representative of the full range of outcomes, but are instead skewed toward unusually successful or remarkable cases. This bias leads people to draw conclusions based only on those who “survived” or succeeded, while overlooking the many whose results were average or poor.​

In the context of personal experiences or online testimonials, individuals with outstanding dutasteride before-and-after photos are far more likely to share their stories because they are proud or excited about their outcomes. Meanwhile, those with modest or disappointing results rarely feel compelled to post. Consequently, the content one encounters online reflects the extremes rather than the typical or average experience.

So, let’s tackle what the typical dose is of oral dutasteride, what you can probably expect in terms of regrowth based on clinical evidence, safety, and what online success looks like.

The most extensively studied and commonly used dosing regimen for dutasteride is 0.5 mg daily, the standard therapy for benign prostatic hyperplasia and the primary off-label dose for hair loss⁶. While lower doses such as 0.2 mg daily have been assessed in at least one clinical trial, the 0.5 mg dose remains the typical standard in clinical and practical settings⁷.

What Results Can I Expect from Oral Dutasteride?

We have created a projected hair regrowth timeline for oral dutasteride – this is based on four studies that we could find using oral dutasteride, including one used for frontal fibrosing alopecia^8–11.

Months 0-3 – No Visible Changes

During the first three months, most people will not notice any regrowth or change, since dutasteride is only beginning to lower DHT levels. At this stage, hair follicles have yet to respond in a way that shows as visible hair improvement.

Months 3-6 – Early Effects Emerge

Between months 3 and 6, initial improvements often become noticeable. Hair may begin to feel thicker, and shedding may reduce. Statistically significant increases in hair count compared to placebo are often observed after the first 12 weeks. Around 22-31% of people may see mild or moderate improvement in global photographic assessments by week 12.

Months 6-9 – First Cosmetic Gains

Visible changes in hair density and coverage commonly appear during this phase. Improvements continue to build, particularly in hair thickening. A Japanese clinical study found that the average hair count rose significantly between 26 and 52 weeks, with 68-87 new hairs seen in a small, defined area. At month six, 75-85% of patients showed some improvement in global photos.

Months 9-15 – Peak Response Phase

Most patients experience their maximum hair regrowth within 12 to 15 months of starting treatment. About 23-25% see “marked improvement” at the one-year point with daily dosing, and both photographic scores and hair counts often continue to show gains through this period. Studies confirm benefits are sustained for at least one year with ongoing therapy.

Months 15-24 – Maintenance Period

Once the peak is reached, most people maintain their results as long as they continue treatment. Improvements either plateau or slightly decrease, but almost always remain much better than baseline. Real-life studies with up to 17 months of follow-up indicate that ongoing therapy stabilizes gains, with rare significant new improvements after the first year.

Months 24-26 – Plateau and Limited Evidence

After two years, the effects of dutasteride tend to level off. Some slight regression or fluctuations may occur, but good adherence helps maintain previous improvements. Real-world data confirm that consistent treatment can sustain benefits at least through this point, though there is little evidence on the effects of using dutasteride for longer than 2-3 years.

Safety

While dutasteride lowers DHT more than finasteride, this does not seem to result in a higher risk of sexual side effects. Large studies show that both drugs have a similar overall rate of side effects, including decreased libido, erectile problems, and changes in ejaculation. For example, in some studies, both drugs caused side effects in about 8-10% of users, with no clear increase for dutasteride, even at higher doses^12–14.

Common Side Effects

More likely to cause sexual side effects like reduced sex drive, erectile dysfunction, problems with ejaculation, and sometimes breast tenderness or enlargement. This is because the drug lowers DHT across the entire body, not just the scalp¹⁵.    

Are Side Effects Less Likely Over Time?

It appears so. Several studies report that the risk of side effects decreases after the first few months of treatment. For example, the rate of sexual side effects dropped from 6% after one year to under 1% after four years of dutasteride use for benign prostatic hyperplasia^13,14. The reasons for this are unclear, but the body may adapt to changes in hormone levels, or people may simply notice new symptoms less over time.

Something else to note is that dutasteride has a long half-life, averaging around 5 weeks¹⁶. This means that it can take several months for the drug to fully clear from the body after stopping treatment, so side effects may also take time to diminish or reverse. If side effects do appear, they may persist for several weeks after discontinuation due to this slow washout period¹⁵.

Now that we have covered some background for oral dutasteride and what you might expect at a clinical level, let’s take a look at ten firsthand accounts shared by real users on Reddit.

Oral Dutasteride Success Stories

The accounts shared below are purely informal and have not been independently verified. They solely reflect the personal experiences of each contributor and should not be interpreted as dependable clinical evidence or as medical recommendations.

Case Report #1: Male (26) – 10 Months on Oral Dutasteride 0.5mg + Oral Minoxidil 5mg Shows Marked Regrowth After Early Shedding

This 26-year-old male previously underwent a 1-year finasteride protocol with minimal response. His physician directed him to a new protocol consisting of oral dutasteride 0.5mg daily and oral minoxidil 5mg daily (starting dose of 2.5mg). 

Ten months into the new therapy, he reported a heavy shedding phase from months 1 to 2, initial thickening and regrowth from months 2 to 3, and continued density gains through the report date. He recently reported a noticeable filling of previously thinned areas and described a strong regrowth response, despite his prior plateau on finasteride. He did not report any sexual or systemic side effects, save for mild arm-hair growth, which he attributes to oral minoxidil.

Case Report #2: Male (31) – 1 Year on Oral Dutasteride 0.5mg + 10 Years on Topical Minoxidil Reports Stronger Strands and Longer Hair Cycles

This 31-year-old male previously used finasteride for 2 years with satisfactory stabilization and considered himself a “hyper responder” to topical minoxidil. He discontinued finasteride due to side effects related to mood, cognition, and sexual function. His current regimen consists of oral dutasteride 0.5mg daily and topical minoxidil (applied across the scalp). 

By month 3 of the regimen, he saw stronger hair growth, improved libido, clearer thinking, and fewer breakouts. Thereafter and through month 8, he experienced a prolonged shedding phase with weaker, brittle hair. After the shedding period and through the report (month 12), he achieved stabilization and renewed thickening, particularly at the crown and mid-scalp. 

Overall, he noted thickening of existing hair shafts, with minimal visible regrowth. He did not report any side effects, but notably described improved mood, cognition, and sexual function compared to his finasteride regimen. 

Case Report #3: Male (31) – 2+ Years on Oral Dutasteride 0.5mg + Sublingual Minoxidil (2.7mg) Shows Sustained Crown Thickening and Regrowth

This 31-year-old male used dutasteride 0.5mg daily. He combined this therapy with compounded sublingual minoxidil at the full dose of 2.7mg daily (titrated up from 0.9mg daily). 

At months 1-3, he noted mild thickening upon switching from finasteride and saw early improvement, including mild crown regrowth by months 3-4. By month 12, he had achieved the majority of the documented visible gains, namely at the crown and mid-scalp. As of this 2-year report, he has described sustained improvement with slight continued thickening. 

He did not report any systemic or sexual side effects and reported excellent compliance and tolerability with sublingual minoxidil. 

Case Report #4: Female (Age Unspecified) – 10 Months on Oral Dutasteride 0.5mg + Oral Minoxidil 0.625mg Reports Major Density Gains and Part-Line Thickening

This female user’s protocol included oral dutasteride 0.5mg daily, oral minoxidil 0.625mg daily (reduced due to water retention), and topical minoxidil, recently added to augment her low oral dose. 

At the 10-month mark, she clearly experienced visible improvement in density compared to baseline, especially at the part. She expressed optimism for continued regrowth via the combination therapy. As noted, the patient had leg edema at the higher oral minoxidil dose (1.25 mg), which resolved after the dose was reduced to 0.625 mg. She reported no side effects from dutasteride, including fatigue or weight gain. 

Case Report #5: Male (29) – 8 Months on Oral Dutasteride 0.5mg + Oral Minoxidil 2.5mg Achieves Near-Full Crown Recovery and Major Density Increase

This user’s protocol included oral minoxidil 2.5mg daily and oral dutasteride 0.5mg daily. As of the report, he has been on minoxidil for 10 months and dutasteride for 8 months. He first noticed regrowth at around month 1 on dutasteride, and by month 8 on dutasteride, his crown and left temple improved significantly, while his right temple still shows room for improvement. 

Overall, he achieved a significant increase in density and appeared to respond well to the oral dutasteride/minoxidil combination. He reported no side effects to date but mentioned faster beard growth. 

Case Report #6: Male (31) – 2 Months on Oral Dutasteride 0.5mg + Oral Minoxidil 2.5mg Reports Rapid Bald Spot Recovery and Early Density Gains

This 31-year-old male’s protocol was oral dutasteride 0.5 mg daily, oral minoxidil 2.5 mg daily, a daily multivitamin, and a collagen supplement. 

After being on dutasteride for 2 months, he experienced a transient libido increase for 7–10 days. Across the first two months, he described visible hair thickening, including the emergence of numerous short hairs. He showed visible new growth, and his hair appeared thicker and stronger.  

He reported no side effects from dutasteride but stated he had increased nasal and cheek hair from oral minoxidil. 

Case Report #7: Male (22) – 3.5 Months on Oral Dutasteride 0.5mg + Oral Minoxidil 5mg + Dermarolling 1.5mm Weekly Achieves Rapid Density Increase

This user’s protocol comprised oral dutasteride 0.5mg daily, oral minoxidil 5mg daily, and dermarolling (1.5mm) once weekly, to which he has adhered for 3.5 months as of the post. By month 2, he experienced significant hair thickening and early regrowth. As of the post, he has achieved significant cosmetic improvements in both hair density and hairline. 

Along with this progress, he reported substantial psychological improvement, stating he felt “better and better” about himself. He reported no side effects and did not mention any irritation or infection associated with dermarolling. He expressed gratitude for learning about hair loss medications rather than undergoing a hair transplant prematurely.

Case Report #8: Male (25) – 14 Months on Oral Dutasteride 0.5mg (Monotherapy) Achieves Visible Regrowth After Finasteride Plateau

This 25-year-old male reported on his progress after 14 months on oral dutasteride 0.5mg daily, and does not report any adjuncts or supplementation. He previously took finasteride for one year, which only stabilized the hair loss. 

For the first 8 months, he reported significant shedding. In months 9-12, the shedding subsided, and he noted a visible thickening of existing hairs. The after photo was taken at month 14 and showed a noticeable improvement in density across thinning hairs. Overall, he reported a significant increase in overall thickness and scalp coverage, with his hairline remaining unchanged. 

He reported no adverse effects and affirmed that he adhered to the protocol throughout the 14 months. 

Case Report #9: Male (23) – 6 Months on Oral Dutasteride 0.5mg (ED → 3×/wk) + Microneedling 1.0mm Weekly Shows Significant Hairline and Temple Regrowth

This user’s protocol consisted of dutasteride 0.5mg daily for the first month, which he tapered down to thrice weekly thereafter. Additionally, he underwent microneedling 1.0 mm weekly using a Derminitor 2 device, lowered from 1.5mm due to excessive bleeding. 

He began to see visible changes at week 4, and by month 3, he states his hair began to look and feel thicker. By month 6, he noted a marked improvement in his hairline and temples, including a darker overall appearance of his hair. He did not report any shedding or noticeable side effects from dutasteride. 

Case Report #10: Male (24) – 3.5 Months on Oral Dutasteride 0.5mg + Topical Minoxidil 2× Daily Exhibits Accelerated Hair Regrowth After Shedding Phase

This 24-year-old male started dutasteride at his dermatologist’s advice. His protocol consisted of oral dutasteride 0.5 mg/day and 5% minoxidil (Rogaine), of which he applied a half capful twice daily. At month 1, he documented an initial shedding phase that resolved at months 2-3.5, upon which he began to notice regrowth. 

At month 3.5, he exhibited a significant increase in visible hair density compared to baseline, with regrowth concentrated at the crown and midscalp. He describes these results as “drastic” and exceeding his expectations. He reported no side effects, aside from mild initial shedding, which naturally resolved. 

Oral vs. Topical Dutasteride: Which is Better?

While we can’t find any direct comparisons between oral and topical dutasteride, one study does provide some insight. 

The study investigated three different treatment approaches for AGA. 30 patients were randomly assigned to one of three groups17. All participants used topical minoxidil 5% lotion twice daily for 16 weeks, with Group B also taking oral dutasteride 0.5 mg daily and Group C receiving monthly microneedling sessions combined with 0.02% topical dutasteride for four months. 

Main Findings

• All participants showed improvements, but the best results were seen in those using topical dutasteride, microneedling, and minoxidil (Group C), who had the greatest gains in hair density and thickness.
• Group A (minoxidil only) had the fewest side effects.
• Using oral dutasteride (Group B) also boosted results but carried a higher risk of adverse effects than topical treatments.

In short, when combined with microneedling, topical dutasteride could work just as well or better than oral dutasteride for hair loss, but with fewer systemic side effects.

So, how do you make a practical decision about which formulation to use? Well, it depends on where you are in your regrowth journey:

• Goal: Maximum regrowth and ok with systemic therapy – You could consider oral dutasteride as a first-line therapy and add other treatments like topical minoxidil and microneedling if needed.
• Goal: Minimize systemic exposure – You could consider topical treatment, combining with minoxidil and adding microneedling for penetration. 
• Partial responder to other treatment (like finasteride): Consider switching to oral dutasteride or adding a topical under clinical guidance.

Don’t forget to maintain realistic expectations. Things to keep in mind include:

• Planning around averages, not anecdotal highlights.
• Giving the treatment at least 6-12 months before deciding to change treatments.
• Using consistent photos to track progress.
• Talk to an expert about combination treatments if you are not seeing early signals by month 6-9.
• Aim for maintenance after peak gains rather than endless improvements.

Summary

Maintaining realistic expectations when undergoing treatment with oral dutasteride is important – regardless of what you see online. Expectations for any hair loss treatment should follow the logic of what is probable vs. what is possible. Together, they should help you understand where you are likely to land in terms of outcome. Regardless, many people end up somewhere in the middle, not at the extremes, which is important to keep frustration at bay and stay committed as you continue your treatment. 

When deciding which formulation to use, you should first understand what your goals are. Once you have answered this question, you can make sustainable, logical decisions about your treatment journey.

References

1. Androgenetic Alopecia in Al-Qalyubia Governorate: A Comprehensive Review. The Egyptian Journal of Hospital Medicine. 2024;95(1):2056-2058. doi:10.21608/ejhm.2024.357762 
2. Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20(12):3759-3781. doi:10.1111/jocd.14537 
3. Prodi DA, Pirastu N, Maninchedda G, et al. EDA2R is associated with androgenetic alopecia. J Invest Dermatol. 2008;128(9):2268-2270. doi:10.1038/jid.2008.60 
4. Nickel JC. Comparison of Clinical Trials With Finasteride and Dutasteride. Rev Urol. 2004;6(Suppl 9):S31-S39. 
5. Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89(5):2179-2184. doi:10.1210/jc.2003-030330 
6. Escamilla-Cruz M, Magaña M, Escandón-Perez S, Bello-Chavolla OY. Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review. Dermatol Ther (Heidelb). 2023;13(8):1721-1731. doi:10.1007/s13555-023-00974-4 
7. Lee S, Kim JE, Lew BL, et al. Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial. Annals of Dermatology. 2025;37(4):183-190. doi:10.5021/ad.25.048 
8. Harcha WG, Martínez JB, Tsai TF, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology. 2014;70(3):489-498.e3. doi:10.1016/j.jaad.2013.10.049 
9. Vañó-Galván S, Saceda-Corralo D, Moreno-Arrones OM, et al. Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: A descriptive monocentric study. Dermatologic Therapy. 2020;33(1):e13182. doi:10.1111/dth.13182 
10. Pindado-Ortega C, Saceda-Corralo D, Moreno-Arrones ÓM, et al. Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice. Journal of the American Academy of Dermatology. 2021;84(5):1285-1294. doi:10.1016/j.jaad.2020.09.093 
11. Tsunemi Y, Irisawa R, Yoshiie H, et al. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. The Journal of Dermatology. 2016;43(9):1051-1058. doi:10.1111/1346-8138.13310 
12. Almudimeegh A, AlMutairi H, AlTassan F, AlQuraishi Y, Nagshabandi KN. Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review. Dermatol Reports. 2024;16(4):9909. doi:10.4081/dr.2024.9909 
13. Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. J Clin Aesthet Dermatol. 2016;9(7):56-62. 
14. Zhou Z, Cui Y, Wu J, Jin H. Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta-analysis of randomized controlled trials. Exp Ther Med. 2020;20(2):1566-1574. doi:10.3892/etm.2020.8851 
15. Tsai T, Choi GS, Kim BJ, et al. Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia. J Dermatol. 2018;45(7):799-804. doi:10.1111/1346-8138.14329 
16. Gisleskog PO, Hermann D, Hammarlund-Udenaes M, Karlsson MO. The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination. Br J Clin Pharmacol. 1999;47(1):53-58. doi:10.1046/j.1365-2125.1999.00843.x 
17. Abu Obeid MN, Abdel Fattah NS, Elfangary MM, Al Husseni RM. Comparison between Topical Minoxidil 5% Alone versus Combined with Dutasteride (Topical 0.02% through Microneedling or Oral 0.5 mg) in Treatment of Androgenetic Alopecia. QJM. 2024;117(Supplement_2):hcae175.207. doi:10.1093/qjmed/hcae175.207